About EMDB
Meet the team
The Electron Microscopy Data Bank (EMDB) team operates out of EMBL-EBI and you can read more about us here.
EMDB history
The EMDB is a public repository for cryogenic-sample Electron Microscopy (cryoEM) volumes and representative tomograms of macromolecular complexes and subcellular structures. It covers a variety of techniques, including single-particle analysis, helical reconstruction, electron tomography, subtomogram averaging, and electron crystallography (for more information, see the EMDB Policies).
EMDB was founded at EMBL-EBI in 2002 under the leadership of Kim Henrick. From 2007, the archive has been operated jointly by EMBL-EBI and the Research Collaboratory for Structural Bioinformatics (RCSB)a. In 2013, the Protein Data Bank Japan (PDBj) also became involved in EMDB. As of the first of January, 2021, EMDB is an archive operated under the aegis of the Worldwide Protein Data Bank (wwPDB), and has also joined that organisation as a full member.
Results of cryo-EM studies are archived in three collaborating archives:
- EMDB stores the processed 3D volumes and tomograms;
- PDB stores any atomic models that have been constructed based on EMDB data;
- EMPIAR stores the raw EM data underpinning the data in EMDB/PDB.
Data for EMDB and PDB can be deposited through the wwPDB deposition and annotation system OneDep.
EMPIAR (Electron Microscopy Public Image Archive) is a companion archive to EMDB, founded at and operated by EMBL-EBI, and with a mirror site at PDBj.
Citing EMDB
Please cite the following publication in your papers and on websites: The wwPDB Consortium, EMDB—the Electron Microscopy Data Bank, Nucleic Acids Research, Volume 52, Issue D1, 5 January 2024, Pages D456–D465, https://doi.org/10.1093/nar/gkad1019
To cite individual entries, please quote the EMDB accession code(s) and cite the original publication(s) in which the entries are described.
EMDB logos and branding should not be used on public-facing websites unless explicit prior permission has been obtained from us. However, if you want to use an EMDB logo in a presentation or report, you can use the images in the following table royalty-free and without the need to obtain prior permission from us.
More information
Please see our FAQ, Policies, description of the EMDB data model, or contact the EMDB helpdesk.
Funding
The work on EMDB at EMBL-EBI has been funded in the past by the European Commission, NIH, UKRI-BBSRC and EMBL-EBI (through the EMBL member states). It is currently funded by the Wellcome Trust and EMBL-EBI.
Quick links
Recent Entries
(Show all)Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1) in the apo state
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-5), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-6), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-2), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 1 (post UDP hydrolysis) after 5 min reaction
Drosophila MSLHAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state overall refinement
MSL HAT nucleosome complex active H4K16Ac state Overall refinement
Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state focused refinement
Drosophila MSL HAT nucleosome complex H4K16ac post-catalytic state
Cryo-EM map of mouse PADI6-UHRF1-UBE2D2 complex (state 2), featuring a tetrameric assembly of PADI6
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4, local
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the inverse agonist cmpd54-4
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P),local
Cryo-EM structure of the MRGPRX4-miniGsq complex bound to the agonist dexamethasone phosphate (DEX-P)
Cryo-EM structure of the MRGPRX4-miniGsq complex in the apo state, local
Drosophila MSL HAT nucleosome complex H4K16ac postcatalytic H3K36me3 reader state
Cryo-EM structure of human TMEM45A with a bound 2-Hydroxypalmitate
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 10, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 7, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 4, Focus map
SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs, focused refinement of RBD and Fab region
SARS-CoV-2 Omicron JD.1.1 spike trimer (S-6P) in complex with 3 R102-9 Fabs and 3 C092 Fabs (3 RBD up)
Human condensin II bound to ADP-BeF3 in autoinhibited conformation
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled mouse brain biopsy frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled yeast cells frozen in HPF Autogrid Planchettes
In-situ structure of the 80S yeast ribosome frozen in HPF Autogrid Planchettes
Cryo-electron tomogram of cryo-FIB milled Tetrahymena thermophila cells frozen in HPF Autogrid Planchettes
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 1, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 1, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 8
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 6
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 10
Nucleosome with an SSb at SHL +5.3 in complex with the WGR domain of PARP2, Class 2, consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 8
Structural Insights into HIV-1 Vif-Mediated Ubiquitination and Degradation of APOBEC3H
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 13
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 12
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of PARP2, Class 2
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (intermediate opening)
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Focused map
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (minimal opening)
Human mitochondrial ClpP in complex with OICR-18704 in the heptameric state
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2, Focused map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 1, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 1, Focus map
Human mitochondrial ClpP in complex with OICR-18704 in a partially-engaged tetradecameric state (maximal opening)
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 8, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3, Focused map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7, Focus map
Nucleosome with an SSD at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 9
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 7, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 4, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 3, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 2, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and EB47, Class 6, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Talazoparib, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 3
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 2
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Olaparib, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 4
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 7
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 5
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2 and HPF1, Class 9, Focus
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 11
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1, and Talazoparib, Class 14, Consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14, Focus map
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 2, focus map
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, consensus map
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, HPF1 and Olaparib, Class 1
Nucleosome with an SSB at SHL +5.3 in complex with human PARP2, Class 14
Nucleosome with an SSB at SHL +5.3 in complex with the WGR domain of human PARP2, Class 1, focus map
Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 2-[5-chloro-1-(4-piperidyl)indol-4-yl]-2,5-diazaspiro[3.4]octan-6-one in the open conformation
Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the open conformation
Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Raw map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in precatalytic conformation
Cryo-EM structure of CRBN bound to 1-[1-(4-piperidyl)indol-4-yl]hexahydropyrimidine-2,4-dione in the closed conformation
Focused map of the disulfide linked complex of T. ramosa IgA peptidase (IgAse2-4) with human IgA2 Fab' in recognition conformation
Cryo-EM structure of monomeric bovine heart cytochrome c oxidase in amphipol A8-35
Cryo-EM structure of homotypic CENP-A nucleosome isolated from human cells
Structure of Human Aspartate--tRNA ligase 3-154 with linker and FC : ATYR0101
Cryo-EM structure of heterotypic CENP-A/H3 nucleosome isolated from human cells
A composite map of the mitochondrial ATP synthase monomer from Acanthamoeba castellanii
CryoEM structure of respiratory complex III intermediate from Acanthamoeba castellanii
Mitochondrial MDH and OSCP in the peripheral stalk of ATP synthase in Acanthamoeba castellanii
Membrane region of Acanthamoeba castellanii mitochondrial ATP synthase dimer
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1, Myb domain focused)
Cryo-EM structure of STITCHR (R2Tg and Cas9 nickase) bound to guide RNA, template RNA, and target DNA in the target-primed reverse transcription initiation state
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 2)
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 3)
A Cryo-EM Map with a Continuous Density of Sld3-CTD Binding on Mcm4-NTD-A and Mcm6-NTD-A
A Local Refined Structure for Sld7 in Complex with Dbf4-bound Mcm6
Cdc45, Sld3 and Sld7 in Complex with DDK-bound MCM Double Hexamer
A Cryo-EM map for Sld3-Sld7 on Cdc45 and DDK-bound MCM Double Hexamer with a Highly Dynamic Sld3N and Sld7N
Cryo-EM structure of R2Tg bound to template RNA and target DNA in the target-primed reverse transcription initiation state (state 1)
CryoEM structure of DDB1-VprBP complex in "ARM-down" conformation
Immune complex comprising the HRSV preF trimer (SC-DM) and the monoclonal antibody Lor69 - Obtained by cryo-EM
Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin (local refined map)
Plasmodium falciparum 17-PF subpellicular microtubule associated with human hemoglobin
Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-2-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
Cis-azomorphine-3 bound mu opioid receptor Gi complex - Focused receptor map
Trans-1-azomorphine-3 bound mu opioid receptor Gi complex - Focused Gi map
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 1
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 2
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 3
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 4
cAMP-bound SthK monomer from symmetry expanded particles - POPE class 2
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 8
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 6
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 7
cAMP-bound SthK monomer from symmetry expanded particles - POPA class 5
cAMP-bound SthK monomer from symmetry expanded particles - POPE class 1
Cryo-EM structure of the flagellar filament in Vibrio parahaemolyticus VP288
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), bound to diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-7), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-4), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 2 (pre-translocation) after 5 min reaction
Structure of Class II chitin synthase, Chs1, from Candida albicans (CaChs1), state 3 (post-translocation) after 5 min reaction
Candida albicans Chitin synthase 1 (CaChs1) bound to UDP-GlcNAc and diynyl arylamine (DA, aka RO-09-3143)
Human CI-M6PR/IGF2R (cation-independent mannose-6-phosphate receptor) cryo-EM structure low pH conformation
Candida albicans Chitin synthase 1 (CaChs1) intermediate state (DA-3), bound to UDP and diynyl arylamine (DA, aka RO-09-3143)




